- Vida Ventures is a Boston-based, next-generation life sciences investment firm
- The $600 million Vida II fund closed on August 1, 2019
Mintz represented Vida Ventures, a next-generation life sciences venture firm, on the $600 million fundraise of its Vida Ventures II, LLC fund. The oversubscribed fund, which closed on August 1, 2019, will be used to further the firm’s life sciences platform.
Mintz Technology Practice Group Chair Dan DeWolf led the representation with Talia Primor, an attorney in our Investment Funds practice.
With the close of Vida II, Vida has approximately $1 billion under management in less than two years since inception.